{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:21:21Z","timestamp":1783189281771,"version":"3.54.6"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,23]],"date-time":"2013-07-23T00:00:00Z","timestamp":1374537600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068445","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T15:46:11Z","timestamp":1374680771000},"page":"e68445","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Impact of Hiv-Associated Conditions on Mortality in People Commencing Anti-Retroviral Therapy in Resource Limited Settings"],"prefix":"10.1371","volume":"8","author":[{"given":"Catherine S.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Spelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Shanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"du Cros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther C.","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Silveira","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Athan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian H.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,7,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries","volume":"367","author":"P Braitstein","year":"2006","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1371\/journal.pmed.0050148","article-title":"Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared","volume":"5","author":"O Keiser","year":"2008","journal-title":"PLoS Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/aid.2007.0217","article-title":"Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings","volume":"24","author":"MC Marazzi","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(10)60666-6","article-title":"Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes","volume":"376","author":"M May","year":"2010","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Alemu AW, Sebastian MS (2010) Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Glob Health Action 3: 5398 - DOI: 10.3402\/gha.v3i0.5398.","DOI":"10.3402\/gha.v3i0.5398"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2334-8-52","article-title":"Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania","volume":"8","author":"A Johannessen","year":"2008","journal-title":"BMC Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1097\/01.aids.0000194802.89540.e1","article-title":"Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design","volume":"19","author":"SD Lawn","year":"2005","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/01.aids.0000226959.87471.01","article-title":"Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study","volume":"20","author":"JF Etard","year":"2006","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"SD Lawn","year":"2006","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7196\/SAMJ.4378","article-title":"Poor long-term outcomes for cryptococcal meningitis in rural South Africa","volume":"101","author":"RJ Lessells","year":"2011","journal-title":"S Afr Med J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy","volume":"46","author":"A Kambugu","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref12","unstructured":"World Health Organisation (2006) Antiretroviral therapy for adults and adolescents in resource-limited settings:towards universal access. Geneva: World Health Organisation."},{"key":"ref13","unstructured":"World Health Organisation (2004) Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. Geneva: World Health Organisation."},{"key":"ref14","unstructured":"Lynen L (2006) Clinical HIV\/AIDS Care Guidelines for Resource-poor Settings. In. Second ed. Brussels: M\u00e9decins Sans Fronti\u00e8res."},{"key":"ref15","unstructured":"World Health Organisation (2004) TB\/HIV: A Clinical Manual, Second Edition. Geneva: World Health Organisation."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.200709-1311PP","article-title":"Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy","volume":"177","author":"SD Lawn","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"G Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1473-3099(10)70170-5","article-title":"Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions","volume":"10","author":"LJ Haddow","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/QAD.0b013e3283390dd1","article-title":"Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy","volume":"24","author":"SD Lawn","year":"2010","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"T Bicanic","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/QCO.0b013e32832fa214","article-title":"Treatment of cryptococcal meningitis in resource limited settings","volume":"22","author":"DJ Sloan","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"ref22","unstructured":"World Health Organisation (2011) Rapid Advice on Diagnosis, Prevention and Management of Cryptococcal Infection in HIV-infected Adults, Adolescents and Children. Geneva: World Health Organisation."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1086\/657405","article-title":"Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action","volume":"51","author":"JN Jarvis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells\/microL who start HIV therapy in resource-limited settings","volume":"51","author":"DB Meya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda","volume":"21","author":"D Moore","year":"2007","journal-title":"AIDS"},{"key":"ref26","unstructured":"World Health Organisation (2010) Antiretroviral therapy for HIV infection in Adults and Adolescents, Recommendations for a public health approach, 2010 revision. Geneva: World Health Organisation."},{"key":"ref27","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ijid.2008.11.013","article-title":"HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death","volume":"13","author":"N Kingkaew","year":"2009","journal-title":"Int J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.5588\/ijtld.10.0440","article-title":"Evaluation of the World Health Organization algorithm for the diagnosis of HIV-associated sputum smear-negative tuberculosis","volume":"15","author":"D Wilson","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e18502","DOI":"10.1371\/journal.pone.0018502","article-title":"Evaluation of the 2007 WHO guideline to improve the diagnosis of tuberculosis in ambulatory HIV-positive adults","volume":"6","author":"O Koole","year":"2011","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e1001067","DOI":"10.1371\/journal.pmed.1001067","article-title":"Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB\/RIF assay: a prospective study","volume":"8","author":"SD Lawn","year":"2011","journal-title":"PLoS Med"},{"key":"ref32","unstructured":"World Health Organisation (2011) Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB\/Rif System. In. Geneva: World Health Organisation."},{"key":"ref33","first-page":"204","article-title":"Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa","volume":"98","author":"BO Ojikutu","year":"2008","journal-title":"S Afr Med J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e1725","DOI":"10.1371\/journal.pone.0001725","article-title":"Overestimates of survival after HAART: implications for global scale-up efforts","volume":"3","author":"GP Bisson","year":"2008","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1086\/597468","article-title":"Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal","volume":"48","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e52019","DOI":"10.1371\/journal.pone.0052019","article-title":"Incidence of WHO Stage 3 and 4 Conditions following Initiation of Anti-Retroviral Therapy in Resource Limited Settings","volume":"7","author":"AJ Curtis","year":"2012","journal-title":"PLoS ONE"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:49:09Z","timestamp":1646182149000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068445"}},"subtitle":[],"editor":[{"given":"Wenzhe","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,23]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068445","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,23]]}}}